Sign in for the best experience.
Our multidisciplinary expert panel has developed recommendations for the management of patients who are receiving long-term oral anticoagulant or antiplatelet therapy and require an elective surgery or procedure.
This guideline addresses the use of vitamin K antagonists (VKAs) like warfarin, perioperative heparin bridging, direct oral anticoagulants (DOACs), and antiplatelet drugs like aspirin (ASA).
ACCESS THE FULL GUIDELINE
In patients receiving VKA therapy for a mechanical heart valve who require VKA interruption for an elective surgery or procedure, we suggest against heparin bridging.
In patients receiving VKA therapy for atrial fibrillation who require VKA interruption for an elective surgery or procedure, we recommend against heparin bridging.
In patients who require DOAC interruption for an elective surgery or procedure, we suggest against perioperative heparin bridging.
In patients receiving ASA who are undergoing elective noncardiac surgery, we suggest ASA continuation over ASA interruption.
Advertisement
Our guidelines are aimed at helping you respond to today’s clinical challenges and improve patient health outcomes. Our panel of experts has developed multimedia content to facilitate adoption of this guideline into your day-to-day practice.
CHEST releases a clinical practice guideline on perioperative management of antithrombotic therapy In a release issued to the media, lead author, James D. Douketis, MD, speaks to the importance of this guideline in practice. An update to the 2012 Perioperative Management of Antithrombotic Therapy guideline, the new guideline is more comprehensive, containing 43 population, intervention, comparator, and outcome questions.
CHEST offers podcasts, networking opportunities, articles, and more on topics relevant to antithrombotic therapy and thrombosis.
Guidelines Oversight Committee Chair, Lisa Moores, MD, FCCP, discusses the 2021 updates to CHEST's antithrombotic therapy recommendations for venous thromboembolism (VTE).
This Network focuses on the scientific knowledge of and clinical practices in cardiovascular medicine and pulmonary vascular disease for health care providers.
Members of the Pulmonary Vascular and Cardiovascular Network review the research on the pulmonary vascular changes and incidence of thrombosis in patients with COVID-19.